Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Curis Inc (CRIS)
NASDAQ:CRIS
Holding CRIS?
Track your performance easily
CRIS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.05 - $17.49
Previous Close$3.08
Volume121.41K
Average Volume (3M)58.64K
Market Cap
$25.99M
Enterprise Value$8.40M
Total Cash (Recent Filing)$20.85M
Total Debt (Recent Filing)$3.26M
Price to Earnings (P/E)―
Beta2.63
Next Earnings
Mar 18, 2025EPS Estimate
-$1.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-7.81
Shares Outstanding8,466,957
10 Day Avg. Volume102,397
30 Day Avg. Volume58,643
Standard Deviation0.70
R-Squared0.06
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-2.99
Price to Sales (P/S)2.53
Price to Cash Flow (P/CF)-1.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.76
Enterprise Value/Gross Profit0.86
Enterprise Value/Ebitda-0.19
Forecast
1Y Price Target
$19.33Price Target Upside527.60% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Curis News
PremiumCompany Announcements
Curis Inc. Reports Positive Q3 2024 Earnings
Ownership Overview
9.80%
Insiders
4.08% Mutual Funds
15.59% Other Institutional Investors
67.21% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CRIS FAQ
What was Curis Inc’s price range in the past 12 months?
Curis Inc lowest stock price was $3.05 and its highest was $17.49 in the past 12 months.
What is Curis Inc’s market cap?
Currently, no data Available
When is Curis Inc’s upcoming earnings report date?
Curis Inc’s upcoming earnings report date is Mar 18, 2025 which is in 86 days.
How were Curis Inc’s earnings last quarter?
Curis Inc released its earnings results on Nov 14, 2024. The company reported -$1.7 earnings per share for the quarter, beating the consensus estimate of -$1.83 by $0.13.
Is Curis Inc overvalued?
According to Wall Street analysts Curis Inc’s price is currently Undervalued.
Does Curis Inc pay dividends?
Curis Inc does not currently pay dividends.
What is Curis Inc’s EPS estimate?
Curis Inc’s EPS estimate is -$1.34.
How many shares outstanding does Curis Inc have?
Curis Inc has 8,466,957 shares outstanding.
What happened to Curis Inc’s price movement after its last earnings report?
Curis Inc reported an EPS of -$1.7 in its last earnings report, beating expectations of -$1.83. Following the earnings report the stock price went up 1.272%.
Which hedge fund is a major shareholder of Curis Inc?
Among the largest hedge funds holding Curis Inc’s share is Maverick Capital ltd. It holds Curis Inc’s shares valued at 3M.
---
Curis Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$19.33 (527.60% Upside)
$19.33 (527.60% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.5%
Last 30 Days ▼ 6.4%
Last 30 Days ▼ 6.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-74.60%
12-Months-Change
Fundamentals
Return on Equity
-436.16%
Trailing 12-Months
Asset Growth
-52.79%
Trailing 12-Months
Company Description
Curis Inc
Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170, and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.
---
CRIS Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlights encouraging clinical trial results and effective cost management, as well as successful fundraising efforts. However, the ongoing net loss and enrollment challenges in the triplet study indicate areas of concern. Overall, the positive aspects of the clinical progress and financial management slightly outweigh the negatives.Read More>---
CRIS Stock 12 Month Forecast
Average Price Target
$19.33
▲(527.60% Upside)
Technical Analysis
Best Analysts Covering CRIS
1 Year
1 Year Success Rate
4/28 ratings generated profit
1 Year Average Return
+0.47%
reiterated a buy rating 3 months ago
Copying Soumit Roy's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of +0.47% per trade.
---